The OMERACT MRI inflammatory arthritis group: advances and future research priorities

Philip G Conaghan; Paul Bird; Fiona McQueen; Charles Peterfy; Pernille Bøyesen; Frédérique Gandjbakhch; Anne Duer-Jensen; Espen A Haavardsholm; Bo Ejbjerg; Charlotte Wiell; Laura Coates; Kay-Geert A Hermann; Philip O'Connor; Marissa Lassere; Jane E Freeston; Allen Anandarajah; Harry Genant; Paul Emery; Mikkel Østergaard

doi:10.3899/jrheum.090349

The OMERACT MRI inflammatory arthritis group: advances and future research priorities

Philip G Conaghan, Paul Bird, Fiona McQueen, Charles Peterfy, Pernille Bøyesen, Frédérique Gandjbakhch, Anne Duer-Jensen, Espen A Haavardsholm, Bo Ejbjerg, Charlotte Wiell, Laura Coates, Kay-Geert A Hermann, Philip O'Connor, Marissa Lassere, Jane E Freeston, Allen Anandarajah, Harry Genant, Paul Emery, Mikkel Østergaard

7 Citations (Scopus)

Abstract

The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group's effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS.

Original language	English
Journal	Journal of Rheumatology
Volume	36
Issue number	8
Pages (from-to)	1803-5
Number of pages	3
ISSN	0315-162X
DOIs	https://doi.org/10.3899/jrheum.090349
Publication status	Published - 2009

Access to Document

10.3899/jrheum.090349

Cite this

Conaghan, P. G., Bird, P., McQueen, F., Peterfy, C., Bøyesen, P., Gandjbakhch, F., Duer-Jensen, A., Haavardsholm, E. A., Ejbjerg, B., Wiell, C., Coates, L., Hermann, K-G. A., O'Connor, P., Lassere, M., Freeston, J. E., Anandarajah, A., Genant, H., Emery, P., & Østergaard, M. (2009). The OMERACT MRI inflammatory arthritis group: advances and future research priorities. Journal of Rheumatology, 36(8), 1803-5. https://doi.org/10.3899/jrheum.090349

Conaghan, PG, Bird, P, McQueen, F, Peterfy, C, Bøyesen, P, Gandjbakhch, F, Duer-Jensen, A, Haavardsholm, EA, Ejbjerg, B, Wiell, C, Coates, L, Hermann, K-GA, O'Connor, P, Lassere, M, Freeston, JE, Anandarajah, A, Genant, H, Emery, P & Østergaard, M 2009, 'The OMERACT MRI inflammatory arthritis group: advances and future research priorities', Journal of Rheumatology, vol. 36, no. 8, pp. 1803-5. https://doi.org/10.3899/jrheum.090349

@article{39043d2085b811df928f000ea68e967b,

title = "The OMERACT MRI inflammatory arthritis group: advances and future research priorities",

abstract = "The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group's effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS.",

author = "Conaghan, {Philip G} and Paul Bird and Fiona McQueen and Charles Peterfy and Pernille B{\o}yesen and Fr{\'e}d{\'e}rique Gandjbakhch and Anne Duer-Jensen and Haavardsholm, {Espen A} and Bo Ejbjerg and Charlotte Wiell and Laura Coates and Hermann, {Kay-Geert A} and Philip O'Connor and Marissa Lassere and Freeston, {Jane E} and Allen Anandarajah and Harry Genant and Paul Emery and Mikkel {\O}stergaard",

note = "Keywords: Arthritis, Psoriatic; Arthritis, Rheumatoid; Humans; Magnetic Resonance Imaging; Research; Rheumatology",

year = "2009",

doi = "10.3899/jrheum.090349",

language = "English",

volume = "36",

pages = "1803--5",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology Publishing Co. Ltd.",

number = "8",

}

TY - JOUR

T1 - The OMERACT MRI inflammatory arthritis group: advances and future research priorities

AU - Conaghan, Philip G

AU - Bird, Paul

AU - McQueen, Fiona

AU - Peterfy, Charles

AU - Bøyesen, Pernille

AU - Gandjbakhch, Frédérique

AU - Duer-Jensen, Anne

AU - Haavardsholm, Espen A

AU - Ejbjerg, Bo

AU - Wiell, Charlotte

AU - Coates, Laura

AU - Hermann, Kay-Geert A

AU - O'Connor, Philip

AU - Lassere, Marissa

AU - Freeston, Jane E

AU - Anandarajah, Allen

AU - Genant, Harry

AU - Emery, Paul

AU - Østergaard, Mikkel

N1 - Keywords: Arthritis, Psoriatic; Arthritis, Rheumatoid; Humans; Magnetic Resonance Imaging; Research; Rheumatology

PY - 2009

Y1 - 2009

N2 - The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group's effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS.

AB - The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group's effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS.

U2 - 10.3899/jrheum.090349

DO - 10.3899/jrheum.090349

M3 - Journal article

C2 - 19671816

SN - 0315-162X

VL - 36

SP - 1803

EP - 1805

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 8

ER -

The OMERACT MRI inflammatory arthritis group: advances and future research priorities

Abstract

Access to Document

Fingerprint

Cite this